BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang HJ, Wang XX, Luo BF, Cong X, Jin Q, Qin H, Zhang HY, Kong XS, Wei L, Feng B. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clin Exp Med 2019;19:299-308. [PMID: 31218578 DOI: 10.1007/s10238-019-00564-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kohla MAS, Fayoumi AE, Akl M, Abdelkareem M, Elsakhawy M, Waheed S, Abozeid M. Early fibrosis regression by shear wave elastography after successful direct-acting anti-HCV therapy. Clin Exp Med 2020;20:143-8. [PMID: 31792631 DOI: 10.1007/s10238-019-00597-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Abdel Moneim A, Suleiman HA, Mahmoud B, Mabrouk D, Zaky MY, Mahmoud B. Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4. Clin Exp Med 2020;20:231-40. [PMID: 32076917 DOI: 10.1007/s10238-019-00605-3] [Reference Citation Analysis]
3 Walters F, Burwell G, Mitchell JJ, Ali MM, Daghigh Ahmadi E, Mostert AB, Jenkins CA, Rozhko S, Kazakova O, Guy OJ. A Rapid Graphene Sensor Platform for the Detection of Viral Proteins in Low Volume Samples. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202100140] [Reference Citation Analysis]
4 Ghosh A, Romani S, Kottilil S, Poonia B. Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal. Int J Mol Sci. 2020;21. [PMID: 33050486 DOI: 10.3390/ijms21207473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hentzien M, Guihot A, de Maindreville D, Tabary T, Brodard V, Vieillard V, Adle-Biassette H, Bani-Sadr F. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. J Neurovirol 2020;26:607-10. [PMID: 32458280 DOI: 10.1007/s13365-020-00848-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Macek Jilkova Z, Saleem K, Afzal S, Decaens T. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021;1:313-21. [DOI: 10.3390/livers1040024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sung PS, Shin EC. Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection. J Clin Med 2021;10:E221. [PMID: 33435135 DOI: 10.3390/jcm10020221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bergantini L, Cameli P, d’Alessandro M, Vagaggini C, Refini R, Landi C, Pieroni M, Spalletti M, Sestini P, Bargagli E. NK and NKT-like cells in granulomatous and fibrotic lung diseases. Clin Exp Med 2019;19:487-94. [DOI: 10.1007/s10238-019-00578-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
9 Rinaldi L, Nevola R, Franci G, Perrella A, Corvino G, Marrone A, Berretta M, Morone MV, Galdiero M, Giordano M, Adinolfi LE, Sasso FC. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics. Cancers (Basel) 2020;12:E1351. [PMID: 32466400 DOI: 10.3390/cancers12061351] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
10 Szereday L, Meggyes M, Berki T, Miseta A, Farkas N, Gervain J, Par A, Par G. Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C. Clin Exp Med 2020;20:219-30. [PMID: 32108916 DOI: 10.1007/s10238-020-00618-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wedemeyer H, Khera T, Strunz B, Björkström NK. Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset? Front Immunol 2020;11:571166. [PMID: 33133084 DOI: 10.3389/fimmu.2020.571166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Feng B, Yang RF, Jiang HJ, Xie YD, Zhang HY, Jin Q, Cong X, Wei L. Correlation analysis of hepatitis C virus core antigen and low viral loads: Can core antigen replace nucleic acid test? Clin Exp Med 2020;20:131-41. [PMID: 31664538 DOI: 10.1007/s10238-019-00588-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]